Table 1.
Toxicity value | “Conditional” predicted | Existing | No value |
---|---|---|---|
Cancer potency value (CPV) | 46 | 16 | 60 |
Oral slope factor (OSF) | 37 | 23 | 62 |
Reference dose (RfD) | 29 | 62 | 31 |
Rfd Benchmark dose (RfD BMD) | 39 | 24 | 59 |
RfD Benchmark dose lower limit (RfD BMDL) | 44 | 10 | 68 |
RfD No observed adverse effect level (RfD NOAEL) | 53 | 34 | 35 |